Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Cash from Operations (2017 - 2025)

Inspire Medical Systems' Cash from Operations history spans 9 years, with the latest figure at 52469000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 24.16% year-over-year to 52469000.0; the TTM value through Dec 2025 reached 116976000.0, down 10.19%, while the annual FY2025 figure was 116976000.0, 10.19% down from the prior year.
  • Cash from Operations for Q4 2025 was 52469000.0 at Inspire Medical Systems, down from 68526000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 69181000.0 in Q4 2024 and bottomed at 12748000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 3161000.0 (2023), against an average of 13166250.0.
  • The largest YoY upside for Cash from Operations was 3541.03% in 2025 against a maximum downside of 175.65% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 734000.0 in 2021, then soared by 2525.2% to 19269000.0 in 2022, then decreased by 10.39% to 17267000.0 in 2023, then skyrocketed by 300.65% to 69181000.0 in 2024, then dropped by 24.16% to 52469000.0 in 2025.
  • Per Business Quant, the three most recent readings for INSP's Cash from Operations are 52469000.0 (Q4 2025), 68526000.0 (Q3 2025), and 2684000.0 (Q2 2025).